
James Dean
Physician-Scientist (Medical Oncology, Biochemistry) with interests and experience in Oncology Clinical Trial design, implementation, monitoring, and analysis -... | Seattle, Washington, United States
*50 free lookup(s) per month.
No credit card required.
James Dean’s Emails ja****@ab****.com
James Dean’s Phone Numbers No phone number available.
Social Media
James Dean’s Location Seattle, Washington, United States
James Dean’s Expertise Physician-Scientist (Medical Oncology, Biochemistry) with interests and experience in Oncology Clinical Trial design, implementation, monitoring, and analysis - including highly translational Early Phase through pivotal, global Late Phase studies and Clinical Pharmacology studies (Phases 1, 2 and 3, Translational Companion Protocols, Expanded Access, Single Patient IND). Proven track record of clinical leadership in FDA and global regulatory approvals, publications, and oncology development team leadership and mentoring. Complementary experiences with regulatory agency interactions, business development activities, strategic clinical development planning,. Clinically trained in Internal Medicine and Oncology with sub-specialization in Genitourinary Oncology and extensive experience in hematologic malignancies (MF, DLBCL, CLL). Clinical and drug development experience in the investigational and marketed drug settings, including antibodies, antibody-drug conjugates, oral kinase inhibitors, and intravenous small molecule chemotherapies in a broad range of hematologic malignancies and solid tumors. Broad-based expertise and experience in Biochemistry, Molecular Biology, Cell Biology and Cancer Biology.
James Dean’s Current Industry Abbvie
James
Dean’s Prior Industry
Fred Hutchinson Cancer Research Center
|
University Of Washington
|
Seattle Genetics
|
Cell Therapeutics
|
Cti Biopharma
|
Pharmacyclics An Abbvie
|
Abbvie
Not the James Dean you were looking for?
Find accurate emails & phone numbers for over 700M professionals.
Work Experience

Abbvie
Executive Medical Director and Global Development Lead, IMBRUVICA and Pediatrics (Oncology)
Thu Jul 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time) — Present
Pharmacyclics An Abbvie
Senior Medical Director
Thu Dec 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) — Thu Jul 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Cti Biopharma
Medical Director
Mon Apr 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time) — Thu Dec 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Cell Therapeutics
Associate Medical Director
Wed Aug 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time) — Fri Mar 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Seattle Genetics
Associate Medical Director
Thu Sep 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) — Fri Jun 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
University Of Washington
Acting Assistant Professor in Medical Oncology
Thu Jul 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time) — Thu Sep 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Fred Hutchinson Cancer Research Center
Associate in Clinical Research
Sat Jul 01 2006 00:00:00 GMT+0000 (Coordinated Universal Time) — Thu Sep 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
University Of Washington
Acting Instructor in Medical Oncology
Sat Jul 01 2006 00:00:00 GMT+0000 (Coordinated Universal Time) — Tue Jun 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time)